Inventor · disambiguated record
Michael Konkel
Also filed as: KONKEL MICHAEL · KONKEL MICHAEL J
6 granted patents·13 pending applications·27 citations·filing 2001–2011
78Inventor score
Top patents by PatentIndex Score
19 records- 0187US7166635B23-imino-2-indolones for the treatment of depression and/or anxietyLUNDBECK & CO AS H·Filed 2005·Granted Jan 23, 2007·8 cites·11 claims
- 0281US7081470B2Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsLUNDBECK & CO AS H·Filed 2003·Granted Jul 25, 2006·15 cites·17 claims
- 0377US7465750B2Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methodsLUNDBECK & CO AS H·Filed 2006·Granted Dec 16, 2008·4 cites·16 claims
- 0462US7868034B2Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsLUNDBECK & CO AS H·Filed 2008·Granted Jan 11, 2011·0 cites·22 claims
- 0560US2009318504A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsBLACKBURN THOMAS P·Filed 2008·Application pending·0 cites
- 0658US2007054910A1Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsKONKEL MICHAEL·Filed 2006·Application pending·0 cites
- 0752US2004106623A1Compounds specific for the human alpha1d adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 0849US2004110821A1GAL3 receptor antagonists for the treatment of affective disordersFiled 2003·Application pending·0 cites
- 0948US2003176314A1Compounds for the treatment of painFiled 2002·Application pending·0 cites
- 1048US2003139431A1Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptorsFiled 2002·Application pending·0 cites
- 1147US2004127502A1Use of GAL3 antagonist for treatment of depressionSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 1244US8198313B2Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsKONKEL MICHAEL·Filed 2011·Granted Jun 12, 2012·0 cites·46 claims
- 1344US2004082615A13-Imino-2-indolones for the treatement of depression and/or anxietyFiled 2003·Application pending·0 cites
- 1441US2006173180A1Aminoalkoxyphenyl indolone derivativesLUNDBECK & CO AS H·Filed 2006·Application pending·0 cites
- 1540US2006173192A1Aminoalkylphenyl indolone derivativesLUNDBECK & CO AS H·Filed 2006·Application pending·0 cites
- 1638US6706716B2Compounds specific for the human α1d adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Mar 16, 2004·0 cites·38 claims
- 1737US2003144310A1Molecules specific for NPFF receptors and uses thereofFiled 2002·Application pending·0 cites
- 1833US2006172989A1Aminoalkoxyphenyl indolone derivativesKONKEL MICHAEL·Filed 2005·Application pending·0 cites
- 1932US2003078271A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Konkel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →